Treatment to slow Alzheimer’s progression given in Cyprus for first time

A 72-year-old woman became the first patient in Cyprus to receive the monoclonal antibody donanemab, in a pioneering treatment for early-stage Alzheimer’s disease administered yesterday at Melathro Agoniston EOKA.

Professor of Neurology at the University of Nicosia Giorgos Kaponidis, the scientific and medical director of Melathro Agoniston EOKA, told Phileleftheros the patient is in the early stages of the disease and first showed symptoms around a year ago....